Treatment for MPDs is tailored to the individual patient and the specific type of disorder. Common approaches include:
Phlebotomy: Used primarily for PV to reduce red blood cell mass and decrease the risk of thrombosis. Medications: Hydroxyurea and Ruxolitinib are commonly used to control blood counts and alleviate symptoms. Interferon-alpha: Used in some cases, especially in younger patients or during pregnancy. Stem Cell Transplant: Considered for patients with high-risk myelofibrosis or those who have transformed to AML.
